The number of clinical studies addressing the role of the NLRP3 inflammasome in diabetes is very limited, but preclinical studies show a possible role of the NLRP3 pathway in the pathophysiology of type 2 diabetes [55,59]. Here, NLRP3 is linked to type 2 diabetes mellitus.